Open Access Open Access  Restricted Access Subscription or Fee Access

Review on Various Analytical Methods Developed for Rifapentine: An Antitubercular Drug

Priyanshu Jain


Rifapentine acts by inhibits DNA-dependent polymer catalyst activity in inclined cells. The clinical and pharmaceutical analysis of this drug needs effective analytical procedures for internal control and pharmacodynamic and pharmacokinetic studies moreover as stability study. an intensive survey of the literature revealed in varied analytical and pharmaceutical chemistry connected journals has been conducted and also the instrumental analytical ways that were developed and used for determination of Rifapentine as single or combination with alternative medication in bulk medication, formulations and biological fluids are reviewed. This review covers 2 totally different analytical ways spectrophotometric ways actinic radiation and natural action technique HPLC and their varied analytical methods.

KeyWords: Rifapentine, UV spectroscopy, HPLC

Full Text:



E. Riva, R. Merati, L. Cavenaghi,

Journal of Chromatography, 1991,

(1–2), 35–40.

Emary W.B., Paul C.T., Mathews B.,

Kay H. Drug Metabolism and

Disposition, 1998; 26(8):. 725–731.

K. Zhou, L.I. Jun, L. Jianhong, Y. Jin,

Chinese Journal of Chemical

Engineering, 2012, 20(3), 602-607.

Benator D., Bhattacharya M.,

Bozeman L. et al. Rifapentine and

isoniazid once a week versus

rifampicin and isoniazid twice a week

for treatment of drug-susceptible

pulmonary tuberculosis in HIVnegative

patients: a Randomized

clinical trial. The Lancet. 2002;


Blumberg H.M., Burman W.J.,

Chaisson RE et al, American Thoracic

Society, Centers for Disease Control

and Prevention, Infectious Diseases

Society of America.Treatment of

Tuberculosis. Am J RespirCrit Care

Med. 2003,167, 603-662.

John A. Jereb, Stefan V Goldberg,

Krista Powell, M. Elsa Villarino,

Phillip Lobue. Centers for Disease

Control and Prevention.

Recommendations for Use of an

Isoniazid- Rifapentine Regimen with

Direct Observation to treat latent

Mycobacterium tuberculosis Infection.

MMWR 2011, 60, 1650-1653.

Xiaobing He, Jiping Wang, Xiaoquan

Liu, Xijing Chen, High-performance

liquid chromatography assay of

rifapentine in human serum Journal of

Chromatography B: Biomedical

Sciences and Applications. Issue

,1996, Vol.681, 412–415.

Riva E, Merati R, Cavenaghi L, High

performance liquid chromatographic

determination of rifapentine and its

metabolite in human plasma by direct

injection into a shielded hydrophobic

phase column, Journal of

Chromatography A,Volume 553,1991,

Vol.553, 35–40, 18th International

Symposium on Chromatography.

Hye S. Lee, Ho C. Shin, Sang S. Han,

Jung K. Roh, High-performance liquid

chromatographic determination of

rifapentine in serum using column

switching, Journal of Chromatography

B: Biomedical Sciences and

Applications, Issue 1,1992, Vol. 574,




Jain Priyanshu and Pathak Vinay

Madhav. Development and validation

of UV-visible spectrophotometric

method for estimation of rifapentine in

bulk and dosage form; Scholars

Research Library, Der Pharma

Chemica, 2013; 5(2):251-255



Kumar AK , Chandra I, Geetha R,

Chelvi KS, Lalitha V, Prema G. A

validated high-performance liquid

chromatography method for the

determination of rifampicin and

desacetyl rifampicin in plasma and

urine, Indian J Pharmacol, 2004;



  • There are currently no refbacks.